cancer

GSK Reaffirms Its Commitment To Oncology Research But The Strategy Is Unclear
Forbes
Wed, 03/30/16 - 10:13 am
GSK
oncology
cancer
R&D
Sanofi-Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round
Fierce Biotech
Wed, 03/30/16 - 10:13 am
Sanofi
Genzyme
ImmuneXcite
cancer
GSK
Study: The FDA's 'breakthrough' program is speeding up cancer approvals
Fierce Biotech
Tue, 03/15/16 - 08:22 am
FDA
drug approvals
cancer
breakthrough therapies
Drug makers would pay for tossing cancer patient waste under RI bill
Stat
Tue, 03/8/16 - 10:15 am
Rhode Island
patients
cancer
Are Drug Companies Reaping Extra Profits By Selling Oversized Doses Of Cancer Drugs?
Forbes
Thu, 03/3/16 - 10:48 am
cancer
Boehringer, AbbVie Said to Be in Cancer-Partnership Talks
Bloomberg
Mon, 02/29/16 - 10:58 am
Boehringer
AbbVie
R&D
cancer
Pharma's Big New Cancer Drug May Be an Old Red Dye
Fortune
Fri, 02/26/16 - 03:21 pm
cancer
Provectus Biopharmaceuticals
melanoma
Kite Pharma's CEO On Cancer-Killing T-Cells: 'This Is A Revolution'
Forbes
Fri, 02/26/16 - 09:36 am
Kite Pharma
cancer
CAR-T
Novartis, Broad researchers find hope in potential gene target for intractable cancers
BioPharma Dive
Tue, 02/23/16 - 09:51 am
Novartis
cancer
R&D
He Built Google Maps. Now He'll Lead The Development Of A Blood Test For Cancer
Forbes
Wed, 02/10/16 - 10:11 am
Jeff Huber
cancer
Google
Grail
diagnostics
Merck bets up to $515M on an epigenetic project for cancer and blood disease
Fierce Biotech
Thu, 01/28/16 - 09:11 pm
Merck
epigenetics
CRUK
blood disease
cancer
R&D
Illumina Starts Cancer Blood Test Firm With Bezos, Gates Backing
Bloomberg
Mon, 01/11/16 - 08:39 am
Illumina
Jeff Bezos
Bill Gates
diagnostics
cancer
Grail
genetic sequencing
Eli Lilly, Pfizer, J&J, AbbVie Join $48M Bet On NYC Cancer Drug Startup
Forbes
Wed, 01/6/16 - 10:26 am
Eli Lilly
Pfizer
JNJ
AbbVie
Petra Pharma
cancer
What Accounts For Low Enrollment In Clinical Trials For Cancer Drugs?
Forbes
Fri, 01/1/16 - 12:59 pm
clinical trials
cancer
Insurers Don't Want to Pay for Pricey Cancer Meds
Motley Fool
Mon, 11/30/15 - 10:14 am
insurers
cancer
3 Cancer Companies to Watch Closely in 2016
Motley Fool
Tue, 10/20/15 - 10:00 am
cancer
Celldex
Medivation
Clovis Oncology
rociletinib
talazoparib
Rintega
Merck, Incyte eye a winning cancer combo with widened collaboration
Fierce Biotech
Tue, 10/13/15 - 09:57 am
Merck
Incyte
cancer
Keytruda
epacadostat
Merck KGaA bets on cancer drugs to revitalize German firm
Yahoo/Reuters
Mon, 10/12/15 - 09:16 am
Merck KGaA
cancer
Merck Serono
Rebif
Erbitux
Cancer Vaccines Make a Comeback, As Third Rock Pumps $55M Into Neon Therapeutics
Forbes
Thu, 10/1/15 - 02:14 pm
cancer
vaccines
Third Rock
Neon Therapeutics
Xoma enters exclusive license agreement with Novartis
Marketwatch
Thu, 10/1/15 - 09:40 am
Xoma
Novartis
cancer
antibodies

Pages